Effects of distal cholesterol biosynthesis inhibitors on cell proliferation and cell cycle progression

Journal of Lipid Research

Volumn 46, Issue 5, 2005, Pages 920-929

  Fernández, Carlos ^a   Martín, Miguel ^a   Gómez Coronado, Diego ^a   Lasunción, Miguel A ^a,b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

7 dehydrocholesterol; HL 60; Sterols

Indexed keywords

1,4 BIS(2 CHLOROBENZYLAMINOMETHYL)CYCLOHEXANE; 4 [2 [1 (4 CHLOROCINNAMYL) 4 PIPERAZINYL]ETHYL]BENZOIC ACID; CHOLESTEROL; ISOPRENOID; STEROL; ZARAGOZIC ACID A; HYPOCHOLESTEROLEMIC AGENT;

ARTICLE; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL STRAIN HL 60; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMYELOCYTE; BIOSYNTHESIS; CELL CYCLE; CELL DIVISION; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ANTICHOLESTEREMIC AGENTS; CELL CYCLE; CELL DIVISION; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HL-60 CELLS; HUMANS;

EID: 27244433832     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M400407-JLR200     Document Type: Article

References (50)

1. Quesney-Huneeus, V., H. A. Galick, M. D. Siperstein, S. K. Erickson, T. A. Spencer, and J. A. Nelson. 1983. The dual role of mevalonate in the cell cycle. J. Biol. Chem. 258: 378-385.
2. Cuthbert, J. A., and P. E. Lipsky. 1990. Inhibition by 6-fluoromevalonate demonstrates that mevalonate or one of the mevalonate phosphates is necessary for lymphocyte proliferation. J. Biol. Chem. 265: 18568-18575.
3. Martínez-Botas, J., A. J. Ferruelo, Y. Suárez, C. Fernández, D. Gómez-Coronado, and M. A. Lasunción. 2001. Dose-dependent effects of lovastatin on cell cycle progression. Distinct requirement of cholesterol and non-sterol mevalonate derivatives. Biochim. Biophys. Acta. 1532: 185-194.
4. Chakrabarti, R., and E. G. Engleman. 1991. Interrelationships between mevalonate metabolism and the mitogenic signaling pathway in T lymphocyte proliferation. J. Biol. Chem. 266: 12216-12222.
5. Tatsuno, I., T. Tanaka, T. Oeda, T. Yasuda, M. Kitagawa, Y. Saito, and A. Hirai. 1997. Geranylgeranylpyrophosphate, a metabolite of mevalonate, regulates the cell cycle progression and DNA synthesis in human lymphocytes. Biochem. Biophys. Res. Commun. 241: 376-382.
6. Chen, H. W., H. J. Heiniger, and A. A. Kandutsch. 1975. Relationship between sterol synthesis and DNA synthesis in phytohemagglutinin-stimulated mouse lymphocytes. Proc. Natl. Acad. Sci. USA. 72: 1950-1954.
7. Kandutsch, A. A., and H. W. Chen. 1977. Consequences of blocked sterol synthesis in cultured cells. DNA synthesis and membrane composition. J. Biol. Chem. 252: 409-415.
8. Fernández, C., M. Lobo, D. Gómez-Coronado, and M. A. Lasunción. 2004. Cholesterol is essential for mitosis progression and its deficiency induces polyploid cell formation. Exp. Cell Res. 300: 109-120.
9. Rujanavech, C., and D. F. Silbert. 1986. LM cell growth and membrane lipid adaptation to sterol structure. J. Biol. Chem. 261: 7196-7203.
10. Chen, H. W., D. A. Leonard, R. T. Fischer, and J. M. Trzaskos. 1988. A mammalian mutant cell lacking detectable lanosterol 14 alphamethyl demethylase activity. J. Biol. Chem. 263: 1248-1254.
11. Martínez-Botas, J., Y. Suárez, A. J. Ferruelo, D. Gómez-Coronado, and M. A. Lasunción. 1999. Cholesterol starvation decreases p34(cdc2) kinase activity and arrests the cell cycle at G2. FASEB J. 13: 1359-1370.
12. Andersson, H. C., L. Kratz, and R. Kelley. 2002. Desmosterolosis presenting with multiple congenital anomalies and profound developmental delay. Am. J. Med. Genet. 113: 315-319.
13. Wechsler, A., A. Brafman, M. Shafir, M. Heverin, H. Gottlieb, G. Damari, S. Gozlan-Kelner, I. Spivak, O. Moshkin, E. Fridman, et al. 2003. Generation of viable cholesterol-free mice. Science. 302: 2087.
14. Esfahani, M., L. Scerbo, and T. M. Devlin. 1984. A requirement for cholesterol and its structural features for a human macrophagelike cell line. J. Cell. Biochem. 25: 87-97.
15. Chen, J. K., T. Okamoto, J. D. Sato, G. H. Sato, and D. B. McClure. 1986. Biochemical characterization of the cholesterol-dependent growth of the NS-1 mouse myeloma cell line. Exp. Cell Res. 163: 117-126.
16. Xu, X., R. Bittman, G. Duportail, D. Heissler, C. Vilcheze, and E. London. 2001. Effect of the structure of natural sterols and sphingolipids on the formation of ordered sphingolipid/sterol domains (rafts). Comparison of cholesterol to plant, fungal, and diseaseassociated sterols and comparison of sphingomyelin, cerebrosides, and ceramide. J. Biol. Chem. 276: 33540-33546.
17. Keller, R. K., T. P. Arnold, and S. J. Fliesler. 2004. Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome. J. Lipid Res. 45: 347-355.
18. Porter, F. D. 2003. Human malformation syndromes due to inborn errors of cholesterol synthesis. Curr. Opin. Pediatr. 15: 607-613.
19. Wassif, C. A., P. Zhu, L. Kratz, P. A. Krakowiak, K. P. Battaile, F. F. Weight, A. Grinberg, R. D. Steiner, N. A. Nwokoro, R. I. Kelley, et al. 2001. Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH/Smith-Lemli-Opitz syndrome. Hum. Mol. Genet. 10: 555-564.
20. Fitzky, B. U., F. F. Moebius, H. Asaoka, H. Waage-Baudet, L. Xu, G. Xu, N. Maeda, K. Kluckman, S. Hiller, H. Yu, et al. 2001. 7-Dehydrocholesterol- dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. J. Clin. Invest. 108: 905-915.
21. Repetto, M., J. C. Maziere, D. Citadelle, R. Dupuis, M. Meier, S. Biade, D. Quiec, and C. Roux. 1990. Teratogenic effect of the cholesterol synthesis inhibitor AY 9944 on rat embryos in vitro. Teratology. 42: 611-618.
22. Kolf-Clauw, M., F. Chevy, C. Wolf, B. Siliart, D. Citadelle, and C. Roux. 1996. Inhibition of 7-dehydrocholesterol reductase by the teratogen AY9944: a rat model for Smith-Lemli-Opitz syndrome. Teratology. 54: 115-125.
23. Kolf-Clauw, M., F. Chevy, B. Siliart, C. Wolf, N. Mulliez, and C. Roux. 1997. Cholesterol biosynthesis inhibited by BM15.766 induces holoprosencephaly in the rat. Teratology. 56: 188-200.
24. Roux, C., C. Horvath, and R. Dupuis. 1979. Teratogenic action and embryo lethality of AY 9944R. Prevention by a hypercholesterolemia-provoking diet. Teratology. 19: 35-38.
25. Gaoua, W., C. Wolf, F. Chevy, F. Ilien, and C. Roux. 2000. Cholesterol deficit but not accumulation of aberrant sterols is the major cause of the teratogenic activity in the Smith-Lemli-Opitz syndrome animal model. J. Lipid Res. 41: 637-646.
26. Gaoua, W., F. Chevy, C. Roux, and C. Wolf. 1999. Oxidized derivatives of 7-dehydrocholesterol induce growth retardation in cultured rat embryos: a model for antenatal growth retardation in the Smith-Lemli-Opitz syndrome. J. Lipid Res. 40: 456-463.
27. Rodriguez, R. J., and L. W. Parks. 1983. Structural and physiological features of sterols necessary to satisfy bulk membrane and sparking requirements in yeast sterol auxotrophs. Arch. Biochem. Biophys. 225: 861-871.
28. Suárez, Y., C. Fernández, B. Ledo, A. J. Ferruelo, M. Martín, M. A. Vega, D. Gómez-Coronado, and M. A. Lasunción. 2002. Differential effects of ergosterol and cholesterol on Cdk1 activation and SRE-driven transcription. Eur. J. Biochem. 269: 1761-1771.
29. Clark, A. J., and K. Bloch. 1959. Function of sterols in Dermestes vulpinus. J. Biol. Chem. 234: 2583-2588.
30. Dahl, J. S., C. E. Dahl, and K. Bloch. 1980. Sterols in membranes: growth characteristics and membrane properties of Mycoplasma capricolum cultured on cholesterol and lanosterol. Biochemistry. 19: 1467-1472.
31. Whitaker, B. D., and D. L. Nelson. 1988. Sterol synergism in Paramecium tetraurelia. J. Gen. Microbiol. 134: 1441-1447.
32. Dahl, C., H. P. Biemann, and J. Dahl. 1987. A protein kinase antigenically related to pp60v-src possibly involved in yeast cell cycle control: positive in vivo regulation by sterol. Proc. Natl. Acad. Sci. USA. 84: 4012-4016.
33. Ramgopal, M., and K. Bloch. 1983. Sterol synergism in yeast. Proc. Natl. Acad. Sci. USA. 80: 712-715.
34. Carrero, P., H. Ortega, J. Martínez-Botas, D. Gómez- Coronado, and M. A. Lasunción. 1998. Flavonoid-induced ability of minimally modified low-density lipoproteins to support lymphocyte proliferation. Biochem. Pharmacol. 55: 1125-1129.
35. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226: 497-509.
36. Fernández, C., Y. Suárez, A. J. Ferruelo, D. Gómez-Coronado, and M. A. Lasunción. 2002. Inhibition of cholesterol biosynthesis by Delta22-unsaturated phytosterols via competitive inhibition of sterol Delta24-reductase in mammalian cells. Biochem. J. 366: 109-119.
37. Honda, M., G. S. Tint, A. Honda, L. B. Nguyen, T. S. Chen, and S. Shefer. 1998. 7-Dehydrocholesterol down-regulates cholesterol biosynthesis in cultured Smith-Lemli-Opitz syndrome skin fibroblasts. J. Lipid Res. 39: 647-657.
38. Brown, M. S., and J. L. Goldstein. 1974. Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7-ketocholesterol. J. Biol. Chem. 249: 7306-7314.
39. Bergstrom, J. D., M. M. Kurtz, D. J. Rew, A. M. Amend, J. D. Karkas, R. G. Bostedor, V. S. Bansal, C. Dufresne, F. L. VanMiddlesworth, O. D. Hensens, et al. 1993. Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase. Proc. Natl. Acad. Sci. USA. 90: 80-84.
40. Labit-Le Bouteiller, C., M. F. Jamme, M. David, S. Silve, C. Lanau, C. Dhers, C. Picard, A. Rahier, M. Taton, G. Loison, et al. 1998. Antiproliferative effects of SR31747A in animal cell lines are mediated by inhibition of cholesterol biosynthesis at the sterol isomerase step. Eur. J. Biochem. 256: 342-349.
41. Mayer, R. J., J. L. Adams, M. J. Bossard, and T. A. Berkhout. 1991. Effects of a novel lanosterol 14 alpha-demethylase inhibitor on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in Hep G2 cells. J. Biol. Chem. 266: 20070-20078.
42. Aufenanger, J., J. Pill, K. Stegmeier, and F. H. Schmidt. 1985. Inhibition of cholesterol biosynthesis by BM 15.766. Horm. Metab. Res. 17: 612-613.
43. Horlick, L. 1966. Effect of a new inhibitor of cholesterol biosynthesis (AY 9944) on serum and tissue sterols in the rat. J. Lipid Res. 7: 116-121.
44. Rahier, A., and M. Taton. 1996. Sterol biosynthesis: strong inhibition of maize delta 5,7-sterol delta 7-reductase by novel 6-aza-B-homosteroids and other analogs of a presumptive carbocationic intermediate of the reduction reaction. Biochemistry. 35: 7069-7076.
45. Silve, S., P. Leplatois, A. Josse, P. H. Dupuy, C. Lanau, M. Kaghad, C. Dhers, C. Picard, A. Rahier, M. Taton, et al. 1996. The immunosuppressant SR 31747 blocks cell proliferation by inhibiting a steroid isomerase in Saccharomyces cerevisiae. Mol. Cell. Biol. 16: 2719-2727.
46. Taton, M., P. Benveniste, and A. Rahier. 1989. Microsomal delta 8,14-sterol delta 14-reductase in higher plants. Characterization and inhibition by analogues of a presumptive carbocationic intermediate of the reduction reaction. Eur. J. Biochem. 185: 605-614.
47. Tuck, S. F., H. Patel, E. Safi, and C. H. Robinson. 1991. Lanosterol 14 alpha-demethylase (P45014DM): effects of P45014DM inhibitors on sterol biosynthesis downstream of lanosterol. J. Lipid Res. 32: 893-902.
48. Nybakken, K., and N. Perrimon. 2002. Hedgehog signal transduction: recent findings. Curr. Opin. Genet. Dev. 12: 503-511.
49. Chevy, F., F. Illien, C. Wolf, and C. Roux. 2002. Limb malformations of rat fetuses exposed to a distal inhibitor of cholesterol biosynthesis. J. Lipid Res. 43: 1192-1200.
50. De Fabiani, E., D. Caruso, M. Cavaleri, M. Galli Kienle, and G. Galli. 1996. Cholesta-5,7,9(11)-trien-3 beta-ol found in plasma of patients with Smith-Lemli-Opitz syndrome indicates formation of sterol hydroperoxide. J. Lipid Res. 37: 2280-2287.